Author/Authors :
Bodakçi, Mehmet Nuri Dicle Üniversitesi - Tıp Fakültesi - Hastanesi Üroloji Anabilim Dalı Diyarbakır, Türkiye , Bozkurt, Yaşar Dicle Üniversitesi - Tıp Fakültesi - Üroloji Anabilim Dalı, Turkey , Atar, Murat Dicle Üniversitesi - Tıp Fakültesi - Üroloji Anabilim Dalı, Turkey , Hatipoğlu, Namık Kemal Dicle Üniversitesi - Tıp Fakültesi - Hastanesi Üroloji Anabilim Dalı Diyarbakır, Türkiye , Penbegül, Necmettin Dicle Üniversitesi - Tıp Fakültesi - Üroloji Anabilim Dalı, Turkey , Söylemez, Haluk Dicle Üniversitesi - Tıp Fakültesi - Üroloji Anabilim Dalı, Turkey , Sancaktutar, Ahmet Ali Dicle Üniversitesi - Tıp Fakültesi - Üroloji Anabilim Dalı, Turkey , Yıldırım, Kadir Dicle Üniversitesi - Tıp Fakültesi - Hastanesi Üroloji Anabilim Dalı Diyarbakır, Türkiye
Abstract :
Objectives: The aim of this study is to evaluate the results of prostate biopsy of patients who had the prostate-specific antigen (PSA) levels below 4 ng/ml. Material and methods: The medical records of 63 patients who underwent transrectal prostate biopsy, between January 2005 and December 2011, due to suspicion of prostate cancer with the PSA levels under 4 ng/ml were retrospectively reviewed. Results: Transrectal Prostate biopsy was performed to 63 patients. Prostate cancer was detected in 12 (19%) patients. The mean value of PSA was 2.5 ng/ml. The Gleason score of Prostate cancer patients was 6,8 (5-7) and the number of positive cores were 3. Conclusions: The rate of prostate cancer was found as 19% in patients with levels of PSA under 4 ng/ml and this ratio is compatible with the results of previous reports.
NaturalLanguageKeyword :
Prostate cancer , prostate , specific antigen , prostate biopsy
